Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents

Trial Profile

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs Aspirin (Primary) ; Aspirin (Primary) ; Clopidogrel (Primary) ; Everolimus; Paclitaxel; Sirolimus; Zotarolimus
  • Indications Coronary artery disease; Coronary stent thrombosis
  • Focus Therapeutic Use
  • Acronyms ADAPT-DES
  • Most Recent Events

    • 28 Jun 2017 Results (n=8374) of meditation analysis assessing effect of platelet reactivity on risk of thrombotic events published in the American Journal of Cardiology
    • 07 Oct 2016 Results published in the American Journal of Cardiology
    • 26 Jul 2013 1-year results published in the Lancet.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top